[Mucoviscidosis, current views on therapy].
D000111:Acetylcysteine / Q000627:therapeutic use; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000328:Adult; D000336:Aerosols; D045930:Anabolic Agents / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000175:diagnosis / Q000188:drug therapy / Q000401:mortality / Q000601:surgery / Q000628:therapy*; D004035:Diet Therapy; D004071:Digitalis Glycosides / Q000627:therapeutic use; D057487:Enzyme Therapy; D005100:Expectorants / Q000627:therapeutic use; D005260:Female; D005767:Gastrointestinal Diseases / Q000628:therapy; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007232:Infant, Newborn, Diseases / Q000188:drug therapy / Q000628:therapy*; D008173:Lung Diseases, Obstructive / Q000628:therapy; D008297:Male; D026741:Physical Therapy Modalities; D012131:Respiratory Insufficiency / Q000628:therapy; D012138:Respiratory Therapy; D014464:Ultrasonic Therapy; D014611:Vaccination; D014815:Vitamins / Q000627:therapeutic use
D000305:Adrenal Cortex Hormones; D000336:Aerosols; D045930:Anabolic Agents; D000900:Anti-Bacterial Agents; D000893:Anti-Inflammatory Agents; D004071:Digitalis Glycosides; D005100:Expectorants; D014815:Vitamins; D000111:Acetylcysteine
Mukoviszidose, der heutige Stand der Therapie.